Concepedia

Publication | Open Access

A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19

DOIFull Paper Access

67

Citations

14

References

2021

Year

Vibeke Backer, Ulf Sjöbring, Jesper Sonne, Anne Weiss, Morten Hostrup, Helle Krogh Johansen, Victoria Becker, David P. Sonne, Torben Balchen, Mads Jellingsø,
The Lancet Regional Health - Europe

Abstract

The study was funded by Innovationsfonden Denmark and UNION therapeutics.

References

YearCitations

Page 1